Tufts Center for the Evaluation of Value and Risk in Health (CEVR) is proud to announce the call for the second annual CEVR Cost-Effectiveness Analysis (CEA) Paper of the Year Award.
Policy makers are increasingly seeking evidence on the value of health care to inform clinical guidelines and reimbursement decisions. At CEVR, we have seen a substantial rise in cost-effectiveness research being produced to meet this need. This award will highlight this important research and promote findings to a broad audience.
We will consider any original, applied CEA in the fields of health and medicine published in 2019 that reports results in terms of incremental cost-per-QALY gained or cost-per-DALY averted. We will judge articles based on:
- Timeliness and importance
- Methodological quality
- Potential influence on policy or clinical decision making
Editorials, commentaries, letters, point/counter-points, scientific reports, and economic analyses reporting endpoints other than cost-per-QALY or cost-per-DALY averted will not be considered.
Application Format and Submission
Anyone – including the authors themselves or any institution, can nominate a paper. Along with a full paper, please submit a structured abstract for the blind review, following the guideline by the 2nd Panel on Cost-effectiveness in Health and Medicine (Table 13.2, p349). In addition to the elements recommended, the abstract should include the title and the impact statement at the end. The abstract may be no longer than 500 words and allows including 1 figure per abstract. To submit an article, or if you have any questions, please email email@example.com by February 29, 2020.
CEVR faculty and staff will select five finalists from among these submissions, and our CEA Registry Advisory Board (comprised of individuals from the life sciences industry, payers, academia, and government) will select the winner, which will be announced in June of 2019. The first author of the winning paper will receive an award of $1,000.